钧达股份(02865):海外持续开拓,持续研发保持技术优势
China Post Securities·2025-11-03 03:14

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative increase in stock price compared to the benchmark index [6][10]. Core Insights - The company reported a revenue of 5.68 billion yuan for the first three quarters of 2025, a year-on-year decrease of 30.7%, with a net profit attributable to shareholders of -420 million yuan, a slight decrease of 0.5% year-on-year [3]. - The overseas sales proportion has significantly increased from 23.85% in 2024 to 51.87% in 2025, with overseas gross margins at 4.5%, up by 2.8 percentage points year-on-year [4]. - The company is actively pursuing N-type technology to reduce costs and improve efficiency, with laboratory efficiency of perovskite tandem batteries reaching 32.08% [5]. Financial Performance Summary - Revenue projections for 2025-2027 are adjusted to 10.0 billion, 12.03 billion, and 14.67 billion yuan respectively, with net profits projected at -510 million, 620 million, and 1.05 billion yuan [6][11]. - The company’s EBITDA is expected to grow significantly from 607.16 million yuan in 2025 to 2.47 billion yuan in 2027, indicating a recovery in profitability [11][12]. - The projected P/E ratios for 2026 and 2027 are 20 and 12 times respectively, reflecting an anticipated improvement in earnings [6].